Ostarine
MK-2866 – 15mg (2 click)
130 clicks/bottle
1 click/7.5mg
🧬 Selective Androgen Receptor Modulator (SARM)
💊 Oral Capsule | Research Compound
Description
Ostarine (MK-2866) is a non-steroidal Selective Androgen Receptor Modulator developed to promote lean muscle preservation and functional strength through targeted activation of androgen receptors in muscle and bone tissue.
🧪 Form and Storage
– 💊 Form: Oral capsules or liquid solution in sealed container
– 🧊 Storage: Store at 15–25°C, protected from moisture and light
– 🕒 Stability: Stable under controlled room temperature conditions
– ⚠️ Keep container tightly sealed
– 🔁 Designed for once-daily administration (half-life ~24 hrs)
🔬 What is Ostarine?
Ostarine (MK-2866) is a first-generation SARM designed to selectively bind to androgen receptors (AR) in skeletal muscle and bone while minimizing stimulation of androgen-sensitive tissues.
It enhances protein synthesis, nitrogen retention, and muscle fiber preservation, making it widely studied in contexts involving muscle wasting, sarcopenia, and physical performance research.
Unlike anabolic steroids, Ostarine does not aromatize to estrogen and exhibits a more favorable anabolic-to-androgenic ratio. However, it remains an experimental compound and is not approved for therapeutic use.
✅ Benefits of Ostarine
● Supports lean muscle mass retention and growth
● Enhances strength and physical performance
● Improves recovery capacity
● Preserves muscle during caloric deficit
● May contribute to bone density support
● Exhibits relatively mild androgenic activity compared to steroids
● Suitable for recomposition and cutting-focused research phases
⚠️ Possible Side Effects
● Dose-dependent testosterone suppression
● Lipid profile changes (HDL reduction)
● Mild headaches or fatigue
● Possible liver enzyme elevation
● Limited long-term human safety data
● Experimental status — not FDA approved
📏 Dosage Guidelines (Research Context)
● Research dosage: 10–20 mg per day
● Cycle duration: 6–8 weeks
● Route of administration: Oral
● Post-cycle hormonal assessment recommended if suppression occurs
🧼 Best Practices
● Maintain consistent once-daily dosing schedule
● Perform baseline and post-cycle blood work
● Monitor testosterone, lipid panel, and liver markers
● Avoid combining with other suppressive compounds without monitoring
● Discontinue use if adverse reactions appear
🧠 Lifestyle and Dietary Considerations
● Maintain adequate protein intake (1.6–2.2 g/kg bodyweight)
● Follow structured resistance training program
● Prioritize 7–9 hours of sleep for hormonal recovery
● Support cardiovascular health with omega-3 fatty acids
● Limit alcohol and processed food intake
💡 Ostarine (MK-2866) is a foundational research SARM known for its balanced anabolic profile and relatively moderate suppressive potential.
Strict monitoring and responsible research application are recommended.
